CreativeOne Wealth LLC Purchases Shares of 15,310 Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL)

CreativeOne Wealth LLC acquired a new position in Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 15,310 shares of the company’s stock, valued at approximately $113,000.

Several other large investors have also added to or reduced their stakes in CCEL. Heron Bay Capital Management bought a new position in Cryo-Cell International in the fourth quarter worth approximately $235,000. Geode Capital Management LLC raised its holdings in Cryo-Cell International by 68.5% during the third quarter. Geode Capital Management LLC now owns 39,860 shares of the company’s stock worth $254,000 after buying an additional 16,203 shares during the last quarter. Finally, Rowlandmiller & PARTNERS.ADV bought a new position in shares of Cryo-Cell International in the fourth quarter valued at $107,000. Institutional investors and hedge funds own 10.44% of the company’s stock.

Analyst Ratings Changes

Separately, Maxim Group lowered their target price on shares of Cryo-Cell International from $9.00 to $8.50 and set a “buy” rating on the stock in a report on Tuesday, March 4th.

Cryo-Cell International Stock Performance

Shares of NYSEAMERICAN:CCEL opened at $5.55 on Tuesday. The company has a market cap of $44.73 million, a P/E ratio of -5.24 and a beta of 0.53. Cryo-Cell International, Inc. has a 12-month low of $4.96 and a 12-month high of $9.50.

Cryo-Cell International Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 18.02%. The ex-dividend date was Friday, February 14th. Cryo-Cell International’s dividend payout ratio is presently -94.34%.

About Cryo-Cell International

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.